WHO WE ARE

Graft Polymer (UK) Plc (LSE: GPL), Established in 2017 by a group of polymer technology experts and venture capitalists, Graft Polymer’s core business comprises polymer modification and the development of drug delivery systems. The Group is a highly innovative business with strong intellectual property holding several patent applications.

Our motto “COMBINE INCOMPATIBLE” clearly defines our business essence, namely to create polymer modifiers to combine immiscible and incompatible components of polymer alloys to achieve high mechanical characteristics, good impact and chemical resistance, fire retardant properties, cost-effectiveness etc

GRAFT POLYMER specializes in customization and adaptation of all our products for any request.
Our expertise and knowledge can offer the best solution for your application requirements

Our innovative Nano-methods of manufacturing technologies can offer a tailored solution or multi-composite structure that can deliver performance, functionality, and economic advantages.

We are welcome any offers from distributors and strategic partners to make new business opportunities.

WHAT CAN WE OFFER

RESEARCH & DEVELOPMENT

Over 20 years of engineering experience guarantee production of new composite materials with unique features.

PRODUCT CUSTOMIZATION ("TURN-KEY")

We provide full product customization for any demand.

COMMERCIAL PRODUCTS

Graft Polymer features a wide range of innovative polymer modifiers and compounds for commercial purposes.

JOINT VENTURES

Polymer modification is a 🔑 for creating polymer composite materials.

ENVIRONMENTAL RESPONSIBILITY